首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities
【2h】

Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities

机译:定量超声和骨矿物质密度:类风湿关节炎及有无椎体畸形对照患者的辨别能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Quantitative ultrasound (QUS) is a reliable tool for discriminating between subjects with and without vertebral deformities in postmenopausal osteoporosis. Less is known about osteoporosis caused by inflammatory diseases or corticosteroid use. >Objectives: (1) To compare in patients with rheumatoid arthritis the ability of QUS and dual energy x ray absorptiometry (DXA) to discriminate between those with and without vertebral deformities; (2) to explore whether the results are similar in population based controls. >Methods: Standardised lateral radiographs of the spine were obtained from 210 patients with rheumatoid arthritis aged over 50 years and 210 individually matched controls. Vertebral deformities were assessed morphometrically and semiquantitatively. All participants underwent bone measurements by DXA (Lunar Expert) and QUS (Lunar Achilles+). Receiver operating curve (ROC) analysis was used to compare the discriminating ability of BMD and QUS measurements in patients and controls with and without vertebral deformities. Analyses were repeated in patients stratified according to corticosteroid use. >Results: For all bone measurements except lumbar spine in the rheumatoid arthritis group, BMD discriminated significantly between the patients with and without vertebral deformities, and the results were similar to those obtained in controls. Among current corticosteroid users, neither QUS nor DXA could discriminate between subjects with and without vertebral deformities. >Conclusions: These findings support QUS as an alternative tool for identifying patients at risk of having vertebral deformities in rheumatoid arthritis, although results should be interpreted with caution in current users of corticosteroids.
机译:>背景:定量超声(QUS)是区分绝经后骨质疏松症有无椎体畸形的可靠工具。对于由炎症性疾病或使用皮质类固醇引起的骨质疏松症知之甚少。 >目的:(1)比较类风湿性关节炎患者QUS和双能X线骨密度仪(DXA)区分椎骨畸形和非椎体畸形的能力; (2)探讨在基于人群的对照中结果是否相似。 >方法:从210名年龄在50岁以上的类风湿关节炎患者和210名单独匹配的对照中获得了标准的脊柱侧位X光片。椎体畸形的形态和半定量评估。所有参与者均通过DXA(月球专家)和QUS(月球跟腱+)进行了骨测量。接受者操作曲线(ROC)分析用于比较BMD和QUS测量值在有或没有椎体畸形的患者和对照组中的辨别能力。根据皮质类固醇使用情况,对分层患者进行了重复分析。 >结果:对于类风湿关节炎组中除腰椎以外的所有骨骼测量结果,BMD在有无椎体畸形和无椎体畸形的患者之间有显着区别,结果与对照组相似。在目前使用皮质类固醇激素的使用者中,QUS和DXA都无法区分有无椎体畸形的受试者。 >结论:这些发现支持QUS作为识别类风湿关节炎中有椎体畸形风险的患者的替代工具,尽管当前使用皮质类固醇激素的使用者应谨慎解释结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号